Granules India recalling over 1.14 crore Naproxen Sodium tablets

13 Sep 2021 Evaluate

Granules India is recalling over 1.14 crore Naproxen Sodium tablets, a non-steroidal anti-inflammatory drug used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, gout, and fever.

According to USFDA, the company's US-based unit is recalling the affected lot due to Current Good Manufacturing Practice (CGMP) deviations. The affected lot has been manufactured at Granules India's Telangana-based plant. The lot has been distributed in the US by New Jersey-based Granules USA, Inc, the report stated. Granules initiated the Class II voluntary recall on August 11 this year.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

597.20 -1.15 (-0.19%)
31-Dec-2025 09:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.90
Dr. Reddys Lab 1262.55
Cipla 1495.00
Zydus Lifesciences 909.95
Lupin 2089.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×